- Home
- Eastbourne Capital Management Llc/ca
Insider Trading History of Eastbourne Capital Management Llc/ca
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Eastbourne Capital Management Llc/ca since 2008.
The trader's CIK number is 1140888.
At the time of the last reporting, Eastbourne Capital Management Llc/ca was the 10% Owner of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
Note that in the past
EASTBOURNE CAPITAL MANAGEMENT LLC/CA also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cassava Sciences Inc (PTIE) by Eastbourne Capital Management Llc/ca
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | PTIE | 0 | $0 | 7,845,670 | $35,318,810 | 0 | $0 |
| 2008 | PTIE | 174,700 | $1,591,717 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mabvax Therapeutics Holdings, Inc. (TELK) by Eastbourne Capital Management Llc/ca
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | TELK | 1,438,615 | $605,934 | 1,625,000 | $1,515,143 | 0 | $0 |
| 2008 | TELK | 561,385 | $191,526 | 4,261,019 | $5,368,883 | 0 | $0 |
Yearly summary of insider trading at Amylin Pharmaceuticals Inc (AMLN) by Eastbourne Capital Management Llc/ca
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | AMLN | 0 | $0 | 3,853,880 | $54,287,588 | 0 | $0 |
| 2008 | AMLN | 3,036,752 | $88,030,490 | 6,026,562 | $126,533,695 | 0 | $0 |
Yearly summary of insider trading at Sarepta Therapeutics, Inc. (AVII) by Eastbourne Capital Management Llc/ca
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | AVII | 0 | $0 | 4,094,646 | $5,077,361 | 0 | $0 |
| 2009 | AVII | 0 | $0 | 333,950 | $475,878 | 0 | $0 |
Yearly summary of insider trading at Mgic Investment Corp (MTG) by Eastbourne Capital Management Llc/ca
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | MTG | 3,061,257 | $2,651,148 | 8,200,245 | $74,131,399 | 0 | $0 |
Insider trading activities at 5 companies by Eastbourne Capital Management Llc/ca:
1. Cassava Sciences Inc (PTIE)
2. Mabvax Therapeutics Holdings, Inc. (TELK)
3. Amylin Pharmaceuticals Inc (AMLN)
4. Sarepta Therapeutics, Inc. (AVII)
5. Mgic Investment Corp (MTG)
Table 1. Insider trading of Cassava Sciences Inc (PTIE) by Eastbourne Capital Management Llc/ca
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-28 | PTIE | Sale | 1,556,842 | 4.99 | 7,763,971 |
| 2009-09-25 | PTIE | Sale | 1,518,000 | 4.97 | 7,552,049 |
| 2009-09-29 | PTIE | Sale | 2,073 | 4.98 | 10,317 |
| 2009-08-07 | PTIE | Sale | 1,663,000 | 3.96 | 6,585,480 |
| 2009-07-13 | PTIE | Sale | 45,778 | 4.19 | 191,626 |
| 2009-07-14 | PTIE | Sale | 45,000 | 4.27 | 192,060 |
| 2009-07-07 | PTIE | Sale | 368,000 | 4.58 | 1,686,176 |
| 2009-06-12 | PTIE | Sale | 185,780 | 5.17 | 961,225 |
| 2009-06-11 | PTIE | Sale | 71,820 | 5.01 | 359,961 |
| 2009-06-15 | PTIE | Sale | 28,103 | 5.06 | 142,313 |
| 2009-06-08 | PTIE | Sale | 286,467 | 5.34 | 1,530,306 |
| 2009-06-09 | PTIE | Sale | 98,969 | 5.28 | 522,160 |
| 2009-06-10 | PTIE | Sale | 75,838 | 5.12 | 388,214 |
| 2009-04-06 | PTIE | Sale | 215,803 | 3.98 | 858,248 |
| 2009-04-03 | PTIE | Sale | 83,663 | 4.10 | 342,850 |
| 2009-04-02 | PTIE | Sale | 600,534 | 4.22 | 2,534,854 |
| 2009-03-02 | PTIE | Sale | 1,000,000 | 3.70 | 3,697,000 |
| 2008-01-14 | PTIE | Buy | 11,450 | 9.75 | 111,637 |
| 2008-01-15 | PTIE | Buy | 8,550 | 9.63 | 82,336 |
| 2008-01-16 | PTIE | Buy | 275 | 9.53 | 2,620 |
| 2008-01-17 | PTIE | Buy | 29,700 | 9.51 | 282,298 |
| 2008-01-22 | PTIE | Buy | 17,325 | 8.89 | 154,019 |
| 2008-02-28 | PTIE | Buy | 25,000 | 8.89 | 222,250 |
| 2008-01-29 | PTIE | Buy | 20,344 | 9.03 | 183,706 |
| 2008-01-30 | PTIE | Buy | 37,056 | 8.95 | 331,651 |
| 2008-02-22 | PTIE | Buy | 10,000 | 8.98 | 89,800 |
| 2008-02-29 | PTIE | Buy | 15,000 | 8.76 | 131,400 |
Table 2. Insider trading of Mabvax Therapeutics Holdings, Inc. (TELK) by Eastbourne Capital Management Llc/ca
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-28 | TELK | Sale | 213,547 | .86 | 184,077 |
| 2009-09-29 | TELK | Sale | 143,068 | .81 | 116,457 |
| 2009-09-30 | TELK | Sale | 47,385 | .80 | 38,002 |
| 2009-09-22 | TELK | Sale | 948,538 | .93 | 877,397 |
| 2009-09-21 | TELK | Sale | 126,653 | .99 | 125,133 |
| 2009-09-16 | TELK | Sale | 104,709 | 1.20 | 125,127 |
| 2009-09-17 | TELK | Sale | 41,100 | 1.19 | 48,950 |
| 2009-02-13 | TELK | Buy | 27,422 | .46 | 12,477 |
| 2009-02-12 | TELK | Buy | 126,202 | .44 | 56,033 |
| 2009-02-11 | TELK | Buy | 22,482 | .46 | 10,229 |
| 2009-02-10 | TELK | Buy | 43,440 | .46 | 19,765 |
| 2009-01-30 | TELK | Buy | 13,617 | .46 | 6,195 |
| 2009-02-02 | TELK | Buy | 31,160 | .46 | 14,177 |
| 2009-01-27 | TELK | Buy | 62,649 | .47 | 29,319 |
| 2009-01-28 | TELK | Buy | 511 | .47 | 242 |
| 2009-01-29 | TELK | Buy | 7,500 | .47 | 3,510 |
| 2009-01-22 | TELK | Buy | 322,809 | .49 | 157,207 |
| 2009-01-20 | TELK | Buy | 29,566 | .45 | 13,422 |
| 2009-01-13 | TELK | Buy | 40,273 | .40 | 15,907 |
| 2009-01-15 | TELK | Buy | 87,485 | .46 | 39,980 |
| 2008-12-31 | TELK | Buy | 485,690 | .36 | 176,305 |
| 2009-01-05 | TELK | Buy | 26,343 | .38 | 10,036 |
| 2009-01-02 | TELK | Buy | 111,466 | .37 | 41,130 |
| 2008-12-29 | TELK | Buy | 146,571 | .32 | 46,756 |
| 2008-12-30 | TELK | Buy | 414,814 | .35 | 144,770 |
| 2008-06-23 | TELK | Sale | 4,261,019 | 1.26 | 5,368,883 |
Table 3. Insider trading of Amylin Pharmaceuticals Inc (AMLN) by Eastbourne Capital Management Llc/ca
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-16 | AMLN | Sale | 2,410,639 | 14.16 | 34,137,058 |
| 2009-09-17 | AMLN | Sale | 1,443,241 | 13.96 | 20,150,530 |
| 2008-08-27 | AMLN | Sale | 6,026,562 | 21.00 | 126,533,695 |
| 2008-06-06 | AMLN | Buy | 150,000 | 29.92 | 4,488,000 |
| 2008-05-07 | AMLN | Buy | 250,000 | 27.90 | 6,975,000 |
| 2008-04-30 | AMLN | Buy | 356,652 | 27.72 | 9,886,393 |
| 2008-04-21 | AMLN | Buy | 894,000 | 29.04 | 25,957,290 |
| 2008-04-16 | AMLN | Buy | 19,471 | 30.78 | 599,317 |
| 2008-04-17 | AMLN | Buy | 50,000 | 30.35 | 1,517,500 |
| 2008-04-14 | AMLN | Buy | 147,308 | 29.42 | 4,333,212 |
| 2008-04-15 | AMLN | Buy | 28,689 | 29.27 | 839,727 |
| 2008-04-11 | AMLN | Buy | 291,300 | 29.98 | 8,733,756 |
| 2008-04-09 | AMLN | Buy | 208,700 | 30.05 | 6,271,435 |
| 2008-04-08 | AMLN | Buy | 50,000 | 30.96 | 1,548,000 |
| 2008-04-07 | AMLN | Buy | 50,000 | 31.52 | 1,576,000 |
| 2008-04-03 | AMLN | Buy | 155,000 | 30.55 | 4,736,025 |
| 2008-03-28 | AMLN | Buy | 118,933 | 28.10 | 3,342,017 |
| 2008-03-26 | AMLN | Buy | 41,067 | 28.05 | 1,152,134 |
| 2008-03-25 | AMLN | Buy | 90,000 | 28.61 | 2,574,900 |
| 2008-03-17 | AMLN | Buy | 30,316 | 24.50 | 742,742 |
| 2008-03-17 | AMLN | Buy | 30,316 | 24.50 | 742,742 |
| 2008-02-29 | AMLN | Buy | 50,000 | 26.59 | 1,329,300 |
| 2008-02-28 | AMLN | Buy | 25,000 | 27.40 | 685,000 |
Table 4. Insider trading of Sarepta Therapeutics, Inc. (AVII) by Eastbourne Capital Management Llc/ca
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-04 | AVII | Sale | 4,094,646 | 1.24 | 5,077,361 |
| 2009-11-11 | AVII | Sale | 333,950 | 1.43 | 475,878 |
Table 5. Insider trading of Mgic Investment Corp (MTG) by Eastbourne Capital Management Llc/ca
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-14 | MTG | Sale | 1,500,000 | 9.16 | 13,735,500 |
| 2009-09-15 | MTG | Sale | 2,100,000 | 9.10 | 19,099,500 |
| 2009-09-16 | MTG | Sale | 4,600,245 | 8.98 | 41,296,399 |
| 2009-03-11 | MTG | Buy | 73,099 | .99 | 72,368 |
| 2009-03-12 | MTG | Buy | 2,988,158 | .86 | 2,578,780 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Eastbourne Capital Management Llc/ca
(10% Owner of Sarepta Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.